-
661
Innovation Patterns in the Canned Fish Industry In Galicia (Spain)
Published 2018-01-01Subjects: Get full text
Article -
662
Changes of plasma cytokines content in Graves’ orbitopathy patients, could be potential markers
Published 2024-04-01Subjects: Get full text
Article -
663
Treat-to-target strategy with secukinumab as a first-line biological disease modifying anti-rheumatic drug compared to standard-of-care treatment in patients with active axial spondyloarthritis: protocol for a randomised open-label phase III study, AScalate
Published 2020-09-01“…This study aims to evaluate the efficacy of a T2T strategy in patients with axSpA, with secukinumab as a first-line bDMARD, compared with standard-of-care (SOC) treatment.Methods and analyses This is a randomised, parallel-group, open-label, multicentre ongoing study in patients with axSpA who are naïve to bDMARD and who have had an inadequate response to NSAIDs. …”
Get full text
Article -
664
Adaptive clinical trial of AZD7442 and SARS-CoV-2 vaccination in immunosuppressed patients highly vulnerable to infection with SARS-CoV-2 virus (RAPID-PROTECTION): protocol for a multicentre, interventional open-label, randomised controlled trial
Published 2025-01-01“…The RAPID-PROTECTION trial will determine the levels of immune protection that AZD7442 offers patients at the very highest risk of SARS-CoV-2 infection and whether this protection can be further enhanced by repeated vaccination against SARS-CoV-2 virus.Methods RAPID-PROTECTION is a multicentre, interventional and open-label adaptive platform trial that aims to recruit 350 immunocompromised participants across five UK centres. …”
Get full text
Article -
665
Safety and efficacy of oral cancer vaccine B440 in patients with PD-1/PD-L1 inhibitor-resistant advanced urothelial cancer: a study protocol for a phase 1 multicenter, open-label, single-arm clinical trial
Published 2025-02-01“…Abstract Background This is a multicenter, open-label, single-arm clinical trial to evaluate the safety and efficacy of oral cancer vaccine B440 in patients with PD-1/PD-L1 inhibitor-resistant advanced urothelial cancer. …”
Get full text
Article -
666
Generalized cross-entropy for learning from crowds based on correlated chained Gaussian processes
Published 2025-03-01Subjects: Get full text
Article -
667
Evaluating the advancements in protein language models for encoding strategies in protein function prediction: a comprehensive review
Published 2025-01-01Subjects: Get full text
Article -
668
Ocular inoculation of toad venom: toxic cataract and proteomic profiling
Published 2025-01-01Subjects: Get full text
Article -
669
Dual-architecture Internet supporting intelligent governance of cyber content
Published 2019-09-01Subjects: Get full text
Article -
670
Multicentre study conducted across centres in the USA, Europe and Australia to assess the safety and effectiveness of a bilateral hypoglossal nerve stimulation system for the treatment of obstructive sleep apnoea in adults: a protocol for a pivotal, multicentre, open-label, single-arm study
Published 2024-12-01Get full text
Article -
671
Protocol for a multicentre, prospective, open-label, randomised controlled trial to compare PROs and safety outcomes between preoperative and postmastectomy radiotherapy in locally advanced breast cancer patients with immediate reconstruction via a deep inferior epigastric perforator flap (CAPPELLA) in China
Published 2025-01-01“…Further evaluation in a randomised trial comparing preoperative radiotherapy versus conventional PMRT in breast reconstruction is required to assess both oncological and patient-reported outcomes (PROs).Methods and analysis The CAPPELLA trial is a prospective, multicentre, open-label, randomised controlled trial across nine centres comparing PROs and safety outcomes between preoperative and postoperative radiotherapy in patients with locally advanced breast cancer requiring immediate DIEP flap reconstruction. …”
Get full text
Article -
672
Automatic Identification of the Main Ionospheric Trough in Total Electron Content Images
Published 2022-06-01Subjects: Get full text
Article -
673
A Test-Retest Study of Single- and Multi-Delay pCASL for Choroid Plexus Perfusion Imaging in Healthy Subjects Aged 19 to 87 Years
Published 2025-03-01Subjects: “…Arterial spin labeling (ASL)…”
Get full text
Article -
674
-
675
Multimodal magnetic resonance imaging studies on non-motor symptoms of Parkinson's disease
Published 2025-06-01Subjects: Get full text
Article -
676
Functional MRI study of neurovascular coupling in patients with non-lesional epilepsy
Published 2025-01-01Subjects: Get full text
Article -
677
Efficacy and safety of surufatinib plus toripalimab in treatment-naive, PD-L1-positive, advanced or metastatic non-small-cell lung cancer and previously treated small-cell lung cancer: an open-label, single-arm, multicenter, multi-cohort phase II trial
Published 2025-02-01“…Here, we report the efficacy and safety of this combination regimen in treatment-naive advanced or metastatic non-small-cell lung cancer (NSCLC) patients with a programmed death-ligand 1 (PD-L1) tumor proportion score (TPS) of 1% or greater (PD-L1-positive) and patients with previously treated small-cell lung cancer (SCLC). Methods This open-label, single-arm phase II study included patients with treatment-naive advanced or metastatic PD-L1-positive NSCLC or previously treated SCLC in China. …”
Get full text
Article -
678
Safety and tumour-specific immunological responses of combined dendritic cell vaccination and anti-CD40 agonistic antibody treatment for patients with metastatic pancreatic cancer: protocol for a phase I, open-label, single-arm, dose-escalation study (REACtiVe-2 trial)
Published 2022-06-01“…This study will determine the safety of DC/anti-CD40 agonistic antibody combination treatment, and treatment-induced tumour-specific immunological responses.Methods and analysis In this open-label, single-centre (Erasmus Univsersity Medical Center, Rotterdam, Netherlands), single-arm, phase I dose finding study, adult patients with metastatic pancreatic cancer with progressive disease after FOLFIRINOX chemotherapy will receive monocyte-derived DCs loaded with an allogeneic tumour lysate in conjunction with a CD40 agonistic antibody. …”
Get full text
Article -
679
The use of artificial intelligence in adapting process of UI design system for end customer requirements
Published 2024-11-01Subjects: Get full text
Article -
680
SILAC-based quantification reveals modulation of the immunopeptidome in BRAF and MEK inhibitor sensitive and resistant melanoma cells
Published 2025-01-01Subjects: Get full text
Article